ACETYLCYSTEINE inhalant Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

acetylcysteine inhalant

cardinal health 107, llc - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine 200 mg in 1 ml - acetylcysteine is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) pulmonary complications of cystic fibrosis tracheostomy care pulmonary complications associated with surgery use during anesthesia post-traumatic chest conditions atelectasis due to mucous obstruction diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) acetylcysteine is contraindicated in those patients who are sensitive to it. acetylcysteine, administered orally, is indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen. it is essential to initiate treatment as soon as possible after the overdose and, in any case, within 24 hours of ingestion. there are no contraindications to oral administration of acetylcysteine in the treatment of acetaminophen overdose.

ACETYLCYSTEINE inhalant Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

acetylcysteine inhalant

american regent, inc. - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine 100 mg in 1 ml - acetylcysteine is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) pulmonary complications of cystic fibrosis tracheostomy care pulmonary complications associated with surgery use during anesthesia post-traumatic chest conditions atelectasis due to mucous obstruction diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) acetylcysteine is contraindicated in those patients who are sensitive to it. acetylcysteine, administered orally, is indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen. it is essential to initiate treatment as soon as po

ACETYLCYSTEINE solution Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

acetylcysteine solution

fresenius kabi usa, llc - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine 100 mg in 1 ml - acetylcysteine solution, usp is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) pulmonary complications of cystic fibrosis tracheostomy care pulmonary complications associated with surgery use during anesthesia post-traumatic chest conditions atelectasis due to mucous obstruction diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) acetylcysteine is contraindicated in those patients who are sensitive to it. acetylcysteine solution, usp administered orally, is indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen. it is essential to initiate trea

ACETYLCYSTEINE solution Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

acetylcysteine solution

hospira, inc. - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine 100 mg in 1 ml - acetylcysteine is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: chronic bronchopulmonary disease     (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) acute bronchopulmonary disease     (pneumonia, bronchitis, tracheobronchitis) pulmonary complications of cystic fibrosis tracheostomy care pulmonary complications associated with surgery use during anesthesia post-traumatic chest conditions atelectasis due to mucous obstruction diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) acetylcysteine is contraindicated in those patients who are sensitive to it. acetylcysteine, administered orally, is indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen. it is essential to initiate treatment as soon as

TRIPLE ANTIBIOTIC- bacitracin zinc, neomycin sulfate, polymyxin b ointment Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

triple antibiotic- bacitracin zinc, neomycin sulfate, polymyxin b ointment

kareway product, inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 400 [usp'u] in 1 g - first aid antibiotic first aid antibiotic first aid antibiotic first aid to help prevent infection in minor: - cuts - scrapes - burns

QUALITY CHOICE TRIPLE ANTIBIOTIC PLUS PAIN RELIEVER- bacitracin zinc, neomycin sulfate, polymyxin-b sulfate, pramoxine hydrochlo Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

quality choice triple antibiotic plus pain reliever- bacitracin zinc, neomycin sulfate, polymyxin-b sulfate, pramoxine hydrochlo

chain drug marketing association inc - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - bacitracin zinc 500 [usp'u] in 1 g - uses help prevent infection and temporarily relieves pain due to - minor cuts - scrapes - burns do not use - in or near the eyes - over large areas of the body - longer than 1 week stop use and ask a doctor if - condition persists or gets worse - symptoms last for more than 7 days or clear up and comes back within a few days - a rash or other allergic reaction occurs directions   adults and children 2 years and older: - clean affected area - apply a small amount (equal to the surface area of the tip of a finger) on area 1 to 3 times daily - may be covered with a sterile bandage   

TRIPLE ANTIBIOTIC OINTMENT- bacitracin zinc, neomycin sulfate, polymyxin b ointment Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

triple antibiotic ointment- bacitracin zinc, neomycin sulfate, polymyxin b ointment

neopharm co., ltd - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 400 [usp'u] in 1 g - first aid antibiotic first aid antibiotic first aid antibiotic first aid to help prevent infection in minor: - cuts - scrapes - burns

ATOPALM FIRST AID TRIPLE ANTIBIOTIC- bacitracin zinc, neomycin sulfate, polymycin b sulfate ointment Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

atopalm first aid triple antibiotic- bacitracin zinc, neomycin sulfate, polymycin b sulfate ointment

neopharm co., ltd. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin zinc 400 [iu] in 1 g - first aid to help prevent infection in minor cuts, scrapes, burns

NEOMYCIN PENICILLIN 100/200 AQUEOUS SUSPENSION FOR INTRAMUSCULAR INJECTION Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neomycin penicillin 100/200 aqueous suspension for intramuscular injection

intervet australia pty limited - neomycin base (as the sulfate); procaine penicillin - parenteral liquid/solution/suspension - neomycin base (as the sulfate) antibiotic active 100.0 mg/ml; procaine penicillin antibiotic-penicillin active 200.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - actinobacillus pleuropneumoniae (haemoph | actinomyces spp. | antibiotic - anti-infective | clostridia | erysipelothrix spp. | escherichia coli (e. coli) | infections of the urinary tracts | klebsiella spp. | leptospirosis | mastitis | metritis | pasteurella multocida | pasteurella spp. | salmonella | staphylococcus aureus | streptococci | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | escherichia coli | feed efficiency | fowl cholera | fungal infections | girth galls | group d streptococcus | including b-lactamase producin | infections | inflammed pads | itching | keratolytic | klebsiella spp. | l. hardjo | l. interrogans | l. pomona | l. tarassovi | lacerations | mastitis | mycoplasmas | odours | open wou

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC, AND HYDROCORTISONE- neomycin sulfate, polymyxin b sulfate, bacitracin zinc a Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates, bacitracin zinc, and hydrocortisone- neomycin sulfate, polymyxin b sulfate, bacitracin zinc a

mwi - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin 3.5 mg in 1 g - neomycin and polymyxin b sulfates, bacitracin zinc, and hydrocortisone ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology). the particular anti-infective drugs in this product